Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
132.90
+0.22 (+0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
March 21, 2023
From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector.
Via
Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
March 20, 2023
Reuters
Via
Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via
News Direct
Topics
Death
Economy
Exposures
COVID-19
Death
Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
By Ernest Dela Aglanu, Benzinga
Via
TheNewswire.com
Topics
Death
Economy
Exposures
COVID-19
Death
Economy
This Is What Whales Are Betting On Moderna
March 17, 2023
Via
Benzinga
Looking At Moderna's Recent Unusual Options Activity
March 14, 2023
Via
Benzinga
Why Moderna Stock Zoomed 7% Higher Today
March 13, 2023
The market takes a prognosticator's new buy recommendation to heart.
Via
The Motley Fool
What 13 Analyst Ratings Have To Say About Moderna
March 13, 2023
Via
Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
With the COVID pandemic still ongoing, having claimed more than 6.8 million lives from about 758 million cases and crippling the global economy, there are several reasons why drug research and...
Via
Benzinga
2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market
March 20, 2023
Both have some headwinds coming up, but their long-term outlook still looks great.
Via
The Motley Fool
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
Via
Benzinga
12-Stock Portfolio -- 25 Growth Stocks to Buy Now
March 19, 2023
If I were starting a new growth stock portfolio today, here are the stocks I'd buy.
Via
The Motley Fool
Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023
March 10, 2023
Via
ACCESSWIRE
Where Will Moderna Be In 5 Years?
March 10, 2023
It might not be making more money in 2028, but it'll likely be a bigger company.
Via
The Motley Fool
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
March 17, 2023
An approved RSV vaccine could be the next big thing for these companies.
Via
The Motley Fool
Is It Time to Buy the S&P 500's 2 Worst-Performing February Stocks?
March 17, 2023
Lumen Technologies and Moderna just tumbled, but are these buying opportunities or falling knives?
Via
The Motley Fool
This High-Growth Company Is Expanding. Time to Buy the Stock?
March 16, 2023
Moderna shares have lost about 15% so far this year.
Via
The Motley Fool
ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies
March 15, 2023
Are you looking for the next trillion-dollar companies? Here are the stocks that ChatGPT thinks will help make you rich in the coming years.
Via
InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
March 15, 2023
These companies have what it takes to grow their revenues -- and their share prices -- over time.
Via
The Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
March 14, 2023
The vaccine stocks Pfizer, Moderna, and Novavax all have approved Covid-19 vaccines. They'll soon need new sources of revenue.
Via
InvestorPlace
Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting
March 14, 2023
Via
ACCESSWIRE
My Hedge Against The Silicon Valley Bank Crisis
March 14, 2023
In other words, the Fed’s response to today’s banking crisis has turned out to be another catalyst driving gold prices higher.
Via
Talk Markets
Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?
March 14, 2023
It might be the beginning of a long road for this trio.
Via
The Motley Fool
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
Via
Benzinga
A Bull Market Is Coming: 5 Top Stocks to Buy Now
March 14, 2023
These companies all have solid long-term prospects.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy In March and Hold Forever
March 13, 2023
Their price is right, and their future is bright.
Via
The Motley Fool
Moderna To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
March 13, 2023
Morgan Stanley raised the price target for NIKE, Inc. (NYSE: NKE) from $138 to $140. Morgan Stanley analyst Alexandra Steiger maintained an Overweight rating. NIKE shares fell 0.1% to $117.45 in...
Via
Benzinga
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold
March 12, 2023
It pays to be an innovator.
Via
The Motley Fool
Novavax Stock: Bear vs. Bull
March 10, 2023
The stock has brought investors eye-popping gains and losses over the past few years.
Via
The Motley Fool
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.